Form 4: Zura Bio CEO Granted 117,000 Share Options
Share Option Grant
Zura Bio's CEO, Robert Lisicki, was granted 117,000 share options on December 9, 2024, vesting over one year.
Summary
- Zura Bio Ltd granted its Chief Executive Officer, Robert Lisicki, 117,000 employee share options on December 9, 2024.
- The options have an exercise price of $2.76 per share.
- These options vest in twelve equal monthly installments over a one-year period starting from October 23, 2024.
- Any remaining unvested options will vest immediately before the next annual shareholder meeting, provided Mr. Lisicki remains in service.
Sentiment
Score: 7
Explanation: The document reflects a standard practice of executive compensation, which is generally viewed positively as it aligns management and shareholder interests. There are no negative implications.
Positives
- The granting of share options aligns the CEO's interests with those of the shareholders.
- The vesting schedule encourages the CEO's continued service with the company.
Risks
- The value of the options is dependent on the future performance of Zura Bio's stock price.
- If the CEO leaves the company before the options fully vest, he may forfeit some or all of the options.
Future Outlook
The share options will vest over the next year, subject to the CEO's continued employment.
Industry Context
Granting share options to executives is a common practice in the biotechnology industry to incentivize performance and align management's interests with shareholders.
Comparison to Industry Standards
- Share option grants are a standard form of executive compensation in the biotech industry, often used to attract and retain talent.
- The vesting schedule of one year is relatively common, although some companies may use longer vesting periods.
- The specific number of options granted and the exercise price would be compared to similar companies of Zura Bio's size and stage of development.
Stakeholder Impact
- Shareholders may view the option grant positively as it incentivizes the CEO to increase shareholder value.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 2024-10-23 | Start date for the monthly vesting of the share options. |
| 2024-12-09 | Date the share options were granted to the CEO. |
| 2024-12-11 | Date of the filing. |
| 2034-12-09 | Expiration date of the share options. |
Keywords
share options, employee compensation, CEO, Zura Bio, equity, vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.